The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 and consists of 13 international organizations with direct involvement in nuclear medicine. The underlying objectives of the NMGI were to promote human health by advancing the field of nuclear medicine and molecular imaging, encourage global collaboration in education, and harmonize procedure guidelines and other policies that ultimately lead to improvements in quality and safety in the field throughout the world. For its first project, the NMGI decided to consider the issues involved in the standardization of administered activities in pediatric nuclear medicine. This manuscript presents Part 1 of the final report of this initial project of the NMGI. It provides a review of the value of pediatric nuclear medicine, current understanding of the carcinogenic risk of radiation as it pertains to the administration of radiopharmaceuticals in children, and the application of dosimetric models in children. A listing of pertinent educational and reference resources available in print and online is also provided. The forthcoming Part 2 report will discuss current standards for administered activities in children and adolescents that have been developed by various organizations and an evaluation of the current practice of pediatric nuclear medicine specifically with regard to administered activities as determined by an international survey of nuclear medicine clinics and centers. Lastly, the Part 2 report will recommend a path forward toward global standardization of the administration of radiopharmaceuticals in children.
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INTRODUCTION
In the summer of 2012, a number of international organizations directly involved in the practice and science of nuclear medicine decided to engage in a project of common interest for the betterment of the field worldwide. The underlying objectives were to promote human health by advancing the field of nuclear medicine and molecular imaging, encourage global collaboration in education, and harmonize procedure guidelines and other policies that ultimately lead to improvements in quality and safety in the field throughout the world. This endeavor was named the Nuclear Medicine Global Initiative (NMGI) and includes societies from various countries as well as several multinational organizations in the field of nuclear medicine ( Table 1 ).
The 13 involved organizations determined that there would be great benefit to the field of nuclear medicine at large in developing a forum in which discussions of important topics of interest could be held. The group recognized that nuclear medicine is a relatively small medical specialty and that professional organizations in the specialty are challenged by limited time and resources. The NMGI is an opportunity for these professional organizations to leverage their strengths and expertise through international cooperation in areas of mutual interest and marks the first time all of the international professional societies of nuclear medicine have worked together to achieve a specific goal.
It was decided that the group would consider a number of potential projects and select one that fulfilled certain criteria. For example, it would need to be of common significant interest for all participants and achievable in a reasonable time frame. If such an endeavor were shown to be fruitful, then a second topic would be selected upon completion of the first project.
The majority of the NMGI participants met at the European Association of Nuclear Medicine (EANM) meeting in Milan in October 2012. After a full discussion, the group decided that the first NMGI project would be to consider the issues involved in the standardization of administered activities in pediatric nuclear medicine. Several groups have developed such guidelines that are clearly of value in the field; however, variations among these guidelines may cause confusion regarding their use, particularly for clinical sites that may not routinely perform imaging of children as well as international groups seeking to establish their own guidelines. In addition, there is a large collection of educational and reference resources, both in print and online, that address the issues involved in the administration of radiopharmaceuticals to children that could be of significant value to nuclear medicine practitioners; thus, a catalog of such resources would be well regarded. In addition, the group decided that a global snapshot of the current practice of pediatric nuclear medicine would be of considerable interest, and therefore an international survey was proposed. A working group was formed to develop and validate a survey instrument.
The report of the Nuclear Medicine Global Initiative will be divided into 2 parts. This is the Part 1 report which provides a review of the value of pediatric nuclear medicine, current understanding of the carcinogenic risk of radiation as it pertains to the administration of radiopharmaceuticals in children, and the application of dosimetric models in children. Gaps in current knowledge on these topics are also discussed. A listing of pertinent educational and reference resources available in print and online is also provided. The Part 2 report will discuss current standards for administered activities in children and adolescents that have been developed by various organizations and an evaluation of the current practice of pediatric nuclear medicine specifically with regard to administered activities as determined by an international survey of nuclear medicine clinics and centers. Lastly, the Part 2 report will recommend a path forward toward global standardization of the administration of radiopharmaceuticals in children.
LITERATURE REVIEW

Value of Pediatric Nuclear Medicine
Nuclear medicine provides physiological information with high sensitivity, and for this reason it is associated with a capability of detecting diseases at an early stage.
Nuclear medicine imaging is commonly performed in adults and children, but the indications for pediatric nuclear medicine are often quite different from those for adults.
Specifically, benign conditions tend to be more commonly performed than malignant diseases in children. In fact, approximately 90% of radionuclide studies in children are for non-oncologic disorders, and almost one-half of pediatric nuclear medicine tests are renal applications in most departments; this figure is similar across the world and has consistently been so over time (1) .
Because of the higher radiosensitivity of biological tissues in children as compared with adults, the radiation dose is a special challenge in this population, as it is for any other diagnostic procedure involving ionizing radiation. There is no standard recommended dose limit for patients; however, because the goal is to provide a better possible standard of care with the available resources in a specific environment, it is generally understood that the radiation dose to children should always be optimized for any necessary medical imaging. This is particularly important for young patients, not only because of radiosensitivity but also because the biological effects of radiation usually appear long after the exposure, and thus the probability of adverse effects is proportional to the expected life span of the individual patient. Hence, all possible efforts should be made to limit the radiation dose to pediatric patients without compromising the diagnostic capabilities of the study (1,2).
Pediatric nuclear medicine provides useful imaging modalities for pediatric patients in many acute care settings (3-6). Dorfman et al. reviewed over 350,000 medical insurance records of children in the US and determined that nuclear medicine comprised only 0.9% of radiologic exams performed in children (4 nuclear medicine exams per 1000 children), the most common exams being bone and thyroid scans (7). In the following, several applications commonly used in pediatric nuclear medicine will be described. Renal imaging procedures are the most commonly performed in pediatric nuclear medicine. Hydronephrosis is a relatively common medical condition that ranges from a reversible dilation to obstructive nephropathy, and scintigraphic evaluation is a standard procedure in the management of this condition in children. The use of diuretics makes differentiation of functional and obstructive dilation easier. In addition, the use of captopril or another angiotensin-converting enzyme inhibitor is helpful in the detection of angiotensin up-regulation, which is a turning point for irreversible renal parenchymal injury and loss of renal function (8, 9) .
Renal cortical scintigraphy using 99m Tc-dimercaptosuccinic acid (DMSA) has been a standard procedure for decades, particularly for the evaluation of pyelonephritis and detection of cortical scars after an acute episode. Interpretation of planar and SPECT images is well established and has low inter-observer variation (10, 11) .
Bone scintigraphy is the second most common procedure in radionuclide examination in children. It is a sensitive method to detect alteration of bone metabolism of any cause and should be correlated with the patient's clinical history and other test results because of its low specificity (12) (13) (14) . Hybrid imaging with CT, such as SPECT/CT and PET/CT, improves specificity and diagnostic accuracy. It is helpful in localizing causes of pain in nonverbal children, small bone and soft tissue lesions in trauma, infection, and tumors and therefore can be used to avoid hospital visits for patients and their parents. Additional radiation exposure from CT is an important consideration and can be avoided by using individually tailored protocols and careful justification.
123 I-metaiodobenzylguanidine (MIBG) scintigraphy for neuroblastoma has high specificity (>90%) and is one of the most common methods of pediatric oncologic imaging.
18 F-FDG PET/CT is increasingly being used in neuroblastoma patients to overcome the limitations of poor spatial resolution and low sensitivity for 123 I-MIBG (15) , and almost every solid malignancy except brain tumors in children and adolescents has high avidity for 18 F-FDG. Other PET tracers, including 11 C-methionine, 18 F-DOPA, 18 F-NaF, 68 Ga-DOTATOC, and DOTANOC, are increasingly used in pediatric nuclear medicine but not as frequently as in adults (16 Identification of epileptogenic foci in children with refractory epilepsy represents a significant diagnostic challenge. MRI frequently fails to reveal an anatomic origin for the seizures, and scalp electroencephalography is often limited to identification of the involved hemisphere. Functional imaging modalities such as PET and SPECT are more useful tools for this application because they reflect the functional pathology associated with the seizure. Although these changes are more easily identified ictally, they can also be detected in the interictal phase, providing relevant information for surgical treatment (17, 18) .
Radiation Risk in Children
Attempting to determine the risk of adverse health effects from exposure of ionizing radiation in the dose range commonly encountered in clinical nuclear medicine is a daunting task. It involves the application of models based on the most current knowledge of pertinent epidemiological and biological data. In practically all cases, the scientific data were acquired in a manner that does not exactly match that of interest in nuclear medicine, and thus it is necessary to extrapolate to the endeavor of interest (eg, According to the models provided by the BEIR VII Phase 2 report, those exposed at an earlier age are in general at higher risk for cancer induction from ionizing radiation than adults. For example, a 1-year-old child and a 10-year-old child may have an approximately 3 times and 2 times higher risk, respectively, of cancer induction than a 40-year-old adult, respectively, for the same level of exposure. In addition, a young girl has a 30-40% higher risk of cancer induction than a young boy with the same level of exposure, mostly due to the risk from breast cancer (Figure 1 ) (25) .
In 2013, the United Nations Scientific Committee on the Effects of Atomic
Radiation (UNSCEAR) issued a report titled "Sources, Effects and Risks of Ionizing
Radiation" (Volume II, Annex B) on the effects of radiation exposure in children. (26) Their 2006 report to the General Assembly stated that lifetime cancer risk estimates for children are uncertain and may be 2 to 3 times higher than those for a population exposed at all ages based on a lifetime projection model that combined all tumor types, which was consistent with the risk estimate provided by the BEIR VII Phase 2 report. However, the 2013 report stated that such generalizations may be misleading because the impression is then that all types of tumors have similar radiosensitivity, which, as pointed out in the report, is not the case. The report included a review of data for 23 types of tumors in regard to the evidence as to whether there was an association with ionizing radiation and whether there was an effect based on the age of exposure (ie, whether younger patients were at higher or lower risk with the same level of exposure). The report indicated that 25% of the types of tumors (including leukemia as well as thyroid, skin, breast, and brain) clearly demonstrated higher radiation sensitivity in younger subjects. In 15% of the types of tumors (including bladder), children had the same level of radiosensitivity as adults. For another 10% of the types of tumors (most notably lung), the risk in younger subjects was lower than that in adults. In the other 50% of types of tumors, the association was either too weak to draw a conclusion regarding the relationship between risk and age (eg, for esophagus) or no evidence that there was a relationship between radiation and tumor induction at any age (Hodgkin's lymphoma, prostate, rectum, or uterus). For 2 types of tumors (leukemia and lung), associations of risk with age were notably different between the BEIR VII Phase 2 report and the 2013 UNSCEAR report.
There was little variation in risk at different ages in the BEIR VII Phase 2 report, whereas there was a markedly higher risk for younger patients in the 2013 UNSCEAR report.
Conversely, the BEIR VII Phase 2 report indicated a higher risk and the 2013 UNSCEAR report reported a slightly lower risk of lung cancer in children.
In summary, children may be considered in general to be at higher risk for adverse health effects from ionizing radiation than adults. Across many types of tumors, children may be 2 to 3 times more sensitive than adults. However, this is not true for all types of tumors; some may demonstrate higher radiosensitivity, some less radiosensitivity, and some similar radiosensitivity to that of adults. More data are necessary to provide reliable, tumor-specific risk estimates.
Pediatric Dosimetric Models
In 
Dosimetry for Commonly Performed Procedures in Children
In 2011, as part of the PEDDOSE.NET research project of the European Union (www.peddose.net), an overview of data on dosimetry for the most commonly used diagnostic radiopharmaceuticals was published as a basis for subsequent recommendations (30, 31) . In summary, data on dosimetry are available for many commonly used radiopharmaceuticals, although the data collection and calculation methods were heterogeneous and most of the data were acquired more than 20 years ago.
However, data on biokinetics and/or absorbed doses for pediatric nuclear medicine applications calculated with clinical data are missing in most cases (31) .
Much of the data on dosimetry for children and adolescents published by the ICRP uses information on biokinetics from adults (32) (33) (34) . The organ residence time (ie, the product of the fraction of the radiopharmaceutical reaching the organ and the effective mean time is in the organ) for adults was used as an input for calculating absorbed doses for children and adolescents using age-dependent (ie, size and weightdependent) mathematical phantoms. Thus, a potential age dependency in pharmacokinetics was not taken into account in much of the data provided by the ICRP.
For example, the data on Tc. An analysis of the diagnostic quality of images was performed with different modeled administered activities (ie, count densities) for anthropomorphic reference phantoms representing two 10-year-old girls with equal weights but different body morphometry. Using BEIR VII age-and sex-specific risk factors, the authors converted absorbed doses to excess risk of cancer incidence and used the values to directly assess the risk of the procedure. This study illustrates that the implementation of a more rigorous approach for balancing the benefits of adequate image quality against the risks of radiation may be preferable to the use of effective dose and also demonstrates that weight-based adjustment to the administered activity might be suboptimal.
Use of the Concept of Effective Dose in Children
According to ICRP 103, effective dose is a protection quantity that provides a dose value related to the probability of health detriment to an adult reference person due to stochastic effects from exposure to low doses of ionizing radiation (27, 28, 36) .
Although references such as ICRP 106 (34) provide conversion factors (mSv per MBq)
for pediatric models, it is a problematic quantity for use in children whose radiosensitivity may be higher than that for adults as previously described. In particular, the effective dose reflects the risk of the nonuniform dose distribution in terms of a uniform or whole body exposure. This is important for medical applications, because most medical exposures consist of nonuniform partial body irradiations.
For comparison of different diagnostic procedures or similar procedures in different hospitals and countries, the effective dose can be very useful. Furthermore, it is a good quantity to compare the use of different technologies for the same medical examination. However, this is true only for patient populations with the same age and sex distribution (27) . For this reason, the effective dose should not be used for epidemiological studies and for sex-specific or an individual dose and risk assessment (27, 37) .
EDUCATIONAL RESOURCES IN PEDIATRIC DOSE OPTIMIZATION
Due to recent public awareness and concerns regarding increasing radiation exposure from medical imaging examinations, this issue has received special attention from several medical professional organizations, industry, patient advocacy groups, and even the media. Although there remains some level of uncertainty regarding dosimetric models and magnitude of the risk to radiation making it prudent to adopt a cautious approach and to further our scientific knowledge on the subject, it is equally important to translate the current scientific findings and understanding into educational and informational resources for use in the clinic. As a result, there are a rising number of educational materials available on the very specialized topic of dose optimization in pediatric nuclear medicine. A catalog of these resources is provided as online reference material for this manuscript (Supplemental Table 1 ). These include further refinement of existing guidelines, harmonization between existing guidelines, new investigations, and development of several new Internet-based web portals containing information and educational materials about dose optimization in pediatric nuclear medicine. Fortunately, most of this educational material can be accessed by both professionals and the general public.
When reviewing these educational materials, it is sometimes difficult to determine the intended targeted audience for a particular publication or web page. (Table 2 For future development, it is important to have the educational content available in several of the most frequently spoken languages in the world. In addition, streamlining the presentation style and web platform used for the educational content would be helpful.
Encouraging the inclusion of radiation dose optimization of medical imaging in general and nuclear medicine in particular in medical school and residency training curricula will help bring needed attention to this very important topic. As new technological developments are introduced in medical imaging, the current guidelines for dose optimization in pediatric nuclear medicine will most likely need to be revised and updated. Therefore, the presentation of educational content will need to be flexible to allow updates and changes in the future.
CONCLUSION
In this Part 1 report, a literature review was performed of application, dosimetry and radiation risk associated with pediatric nuclear medicine. In addition, a review of the educational and informational resources available in print or online in presented. This report sets the stage for the Part 2 report which will present a review and comparison of existing guidelines for administered activities in children and adolescents, and the results of a global survey on the current state of the practice of pediatric nuclear medicine. The
Part 2 report will also present conclusion and recommendations of the initial project of the nuclear Medicine Global Initiative.
The application of nuclear medicine in the pediatric population has been shown to be of great value in a variety of clinical applications including cardiology, urology, neurology, orthopedics and oncology. However, it is well-believed that children are at a higher risk for adverse effects from ionizing radiation than adults and, thereby, it is prudent to be more cautious when determining the administered activities for studies in children. This can be challenging since the dosimetric models available for children and adolescents are not as well established as they are in adults, particularly with respect to biodistribution of radiopharmaceuticals. There are a variety of educational and informational resources regarding the practice, dosimetry and radiation risk associated with pediatric nuclear medicine. This report provides a list of links to many such resources that should be of clear value to the nuclear medicine practitioner. 
